MyAverix Finance
SHG · Healthcare
Hainan Huluwa Pharmaceutical Group Co Ltd (605199)
Drug Manufacturers - Specialty & Generic
Hainan Huluwa Pharmaceutical Group Co Ltd (605199) is listed on SHG in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-29, reported market cap is $2.57B, P/E ratio is 18.00, net margin is -15.8%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 605199
Hainan Huluwa Pharmaceutical Group Co Ltd (605199) — FAQ
What is Hainan Huluwa Pharmaceutical Group Co Ltd's market cap?
Hainan Huluwa Pharmaceutical Group Co Ltd (605199) has a reported market cap of $2.57B (data as of 2026-03-29).
What is 605199's P/E ratio?
The price-to-earnings (P/E) ratio for Hainan Huluwa Pharmaceutical Group Co Ltd (605199) is 18.00 (data as of 2026-03-29).
Does Hainan Huluwa Pharmaceutical Group Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Hainan Huluwa Pharmaceutical Group Co Ltd (605199). Check the MyAverix Finance app for the latest dividend data.
What sector is Hainan Huluwa Pharmaceutical Group Co Ltd in?
Hainan Huluwa Pharmaceutical Group Co Ltd (605199) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 605199 listed on?
605199 is listed on SHG.
What is Hainan Huluwa Pharmaceutical Group Co Ltd's net margin?
Hainan Huluwa Pharmaceutical Group Co Ltd (605199) reports a net margin of -15.8% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.